About Vetbiobank
Vetbiobank is a Healthcare company founded in 2011. Veterinary regenerative medicine. Vetbiobank has raised $450.24 thousand across 3 funding rounds from investors including European Union, EIC Fund and Health Angels Rhône-Alpes. Its chief executive, as recorded, is Stephane Maddens. Vetbiobank offers products and services including CANIPREN, FELIPREN, and EQUIPREN. Its focus areas include HealthTech, Veterinary HealthTech, Biopharmaceuticals and Companion Animals.
Company details
Vetbiobank was founded in 2011 within the veterinary regenerative medicine sector. Therapeutic products derived from neonatal stem cells are developed, produced, and marketed to address chronic inflammatory conditions in horses, dogs, and cats. Operations center on utilizing biological resources for pet health treatments, with a focus on established animal species.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vetbiobank.com
- Social LinkedIn X Facebook
- Total Equity Funding$450.24K (USD)
in 3 rounds
- Latest Funding Round$55.1K (USD), Grant
Aug 2019
- InvestorsEuropean Union
& 3 more
Products & Services of Vetbiobank
Vetbiobank offers a comprehensive portfolio of products and services, including CANIPREN, FELIPREN, and EQUIPREN.
Treatment for canine arthritis using neonatal stem cells.
Therapies for feline diseases like gingivostomatitis.
Solutions for equine arthritis and related conditions.
Funding Insights of Vetbiobank
Vetbiobank has successfully raised a total of $450.24K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $55.1 thousand completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $450,237
- Total Rounds 3
- Last Round Grant — $55,104
- First Round $450,237
(Jul 2013)
- Investors Count 4
All 3 funding rounds of Vetbiobank with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2019 | $55,104 | Grant | – | – | |
| May 2019 | $56,002 | Grant | – | – | |
| Jul 2013 | $450,237 | Seed | – | Health Angels Rhone-Alpes, Angelor | – |
4 investors in total: 4 institutional.
Investors in Vetbiobank
Vetbiobank has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Health Angels Rhône-Alpes.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Health Angels Rhône-Alpes is focused on funding health innovations. | health-angels-ra.com | Lyon, France | ||
| angelor.biz | ||||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Vetbiobank
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vetbiobank
3 people are tracked at Vetbiobank (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Stephane Maddens | CEO | Leadership |
Nadia Plantier | COO - Business Development - Sales & Marketing | Leadership |
Martine Cours | Business developper | Team |
Complete people profiles for Vetbiobank
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vetbiobank
3 dated milestones of Vetbiobank across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Vetbiobank is founded.
- Funding First funding round of $450K.
- Funding Latest funding round, Grant, of $55K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vetbiobank
Vetbiobank was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Stephane Maddens is the CEO of Vetbiobank, as recorded in our data.
Vetbiobank is a funded company, having raised a total of $450.24K across 3 funding rounds to date. The company's 1st funding round was a Seed of $450.24K, raised on Jul 2013.
Vetbiobank was founded in 2011 within the veterinary regenerative medicine sector. Therapeutic products derived from neonatal stem cells are developed, produced, and marketed to address chronic inflammatory conditions in horses, dogs, and cats. Operations center on utilizing biological resources for pet health treatments, with a focus on established animal species.
Vetbiobank offers CANIPREN, FELIPREN, and EQUIPREN.
Vetbiobank has 4 investors. Key investors include European Union, EIC Fund, Health Angels Rhône-Alpes, and Angelor.